ConductScience.org, home

Paper29540327

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.

Avila MS and 20 others. J Am Coll Cardiol, 2018. Cited by 415 papers, by iCite.

Cite this record

ConductScience Library. Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial. Papers, record 29540327. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29540327

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.
PubMed
Journal
J Am Coll Cardiol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
415
iCite
Relative citation ratio, by iCite
16.1
iCite
Revised in PubMed
2022-03-21
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Avila MSMônica Samuel
2Ayub-Ferreira SMSilvia Moreira
3de Barros Wanderley MR JrMauro Rogerio
4das Dores Cruz FFatima
5Gonçalves Brandão SMSara Michelly
6Rigaud VOCVagner Oliveira Carvalho
7Higuchi-Dos-Santos MHMarília Harumi
8Hajjar LALudhmila Abrahão
9Kalil Filho RRoberto
10Hoff PMPaulo Marcelo
11Sahade MMarina
12Ferrari MSMMarcela S M
13de Paula Costa RLRomulo Leopoldo
14Mano MSMax Senna
15Bittencourt Viana Cruz CBCecilia Beatriz
16Abduch MCMaria Cristina
17Lofrano Alves MSMarco Stephan
18Guimaraes GVGuilherme Veiga
19Issa VSVictor Sarli
20Bittencourt MSMarcio Sommer

Source PubMed

See all 21 authorsDownload CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
Antineoplastic AgentsMajor topic
CardiotoxicityMajor topic
CarvedilolMajor topic
Adult
Breast Neoplasms
Double-Blind Method
Female
Follow-Up Studies
Humans
Middle Aged
Prospective Studies

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01724450Carvedilol Effect in Preventing Chemotherapy - Induced CardiotoxicityDerived from the trialYesClinicalTrials.gov
NCT06005259Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)BackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in29773156Beta-Blockers for Primary Prevention of Anthracycline Cardiotoxicity: Not Quite Ready for Prime Time.https://conductscience.org/library/papers/29773156PubMed
Comment in30165996Can Carvedilol Prevent Chemotherapy-Related Cardiotoxicity?: A Dream to Be Balanced With Tolerability.https://conductscience.org/library/papers/30165996PubMed
Comment in30165997Reply: Can Carvedilol Prevent Chemotherapy-Related Cardiotoxicity?: A Dream to Be Balanced With Tolerability.https://conductscience.org/library/papers/30165997PubMed

Download CSV of comments and corrections

Cited by297

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 415 citations.

PMIDTitleJournalYearIn PapersSource
42958440Pharmacologic prevention of cardiotoxicity in breast cancer: a Bayesian network meta-analysis and meta-regression.Cardiooncology2026https://conductscience.org/library/papers/42958440PubMed
42938878Cardiovascular Magnetic Resonance for Early Detection of Cancer Therapy-Related Cardiac Dysfunction: From Multiparametric Tissue Signatures to Clinical Pathways.Cancers (Basel)2026https://conductscience.org/library/papers/42938878PubMed
42920518Efficacy of beta-blockers in preventing cardiotoxicity in breast cancer patients receiving anthracyclines: a GRADE-assessed systematic review and meta-analysis with trial sequential analysis.Front Cardiovasc Med2026https://conductscience.org/library/papers/42920518PubMed
42836855Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial.Future Sci OA2026https://conductscience.org/library/papers/42836855PubMed
42739599Cardio-Oncology in Older Adults: Evidence Gaps, Geriatric Considerations, and Future Directions.J Clin Med2026https://conductscience.org/library/papers/42739599PubMed
42614945Beyond β-Adrenergic Receptor Brake: Compartment-Selective GRK2 Programs from Heart Failure to Cardio-Oncology.Kinases Phosphatases2026https://conductscience.org/library/papers/42614945PubMed
42554547Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective: JACC CardioOncology State-of-the-Art Review.JACC CardioOncol2026https://conductscience.org/library/papers/42554547PubMed
42505901Sacubitril/Valsartan for Prevention of Cancer Therapy-Related Cardiac Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.J Cardiovasc Dev Dis2026https://conductscience.org/library/papers/42505901PubMed
42455418Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists.Cardiovasc Toxicol2026https://conductscience.org/library/papers/42455418PubMed
42384221From Cardioprotection to Trial Design: Rethinking Cardiac Safety in Oncology.Curr Heart Fail Rep2026https://conductscience.org/library/papers/42384221PubMed
42356463Carvedilol Exerts Cardioprotective Effects Against Doxorubicin Toxicity via Autophagy Modulation and Energetics Restoration.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356463PubMed
42253929
Short-Term, Cycle-Synchronized Adjunctive Therapy With Crocus Total Glucosides Tablets for Cardiac Protection Against Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
MedComm (2020)2026https://conductscience.org/library/papers/42253929PubMed
42181413Sodium-Glucose Cotransporter-2 Inhibitors in Anthracycline-Treated Cancer Patients: A Narrative Review of Emerging Cardioprotective Evidence.Cureus2026https://conductscience.org/library/papers/42181413PubMed
42104505Clinical utility of the HFA-ICOS risk tool in real-world HER2-positive breast cancer patients receiving therapy.Cardiooncology2026https://conductscience.org/library/papers/42104505PubMed
42057201Cardiovascular care in adult cancer survivorship post-therapy: a cross-sectional analysis of clinical practice guidelines.Cardiooncology2026https://conductscience.org/library/papers/42057201PubMed
42045526A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction.Commun Med (Lond)2026https://conductscience.org/library/papers/42045526PubMed
41993860Protective effects of beta-blockers against anthracycline- and trastuzumab-related cardiotoxicity: a systematic review based on conventional and Bayesian network meta-analysis.Front Cardiovasc Med2026https://conductscience.org/library/papers/41993860PubMed
41977162Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction.Int J Mol Sci2026https://conductscience.org/library/papers/41977162PubMed
41975552Review on cardioprotective strategies in the setting of chemotherapy-induced cardiotoxicity.Cardiooncology2026https://conductscience.org/library/papers/41975552PubMed
41971817Discovery of Zidovudine as a cardiomyocyte protectant for doxorubicin-induced toxicity through high-throughput phenotypic drug screening.Fundam Res2026https://conductscience.org/library/papers/41971817PubMed

See all 297 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064

Source NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
CARVEDILOLCHEMBL723Derived from the trial1https://conductscience.org/library/drugs/CHEMBL723

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29540327

GET https://conductscience.org/api/papers/v1/29540327/authors?page=2